Protein name:
Erythrocyte membrane protein band 4.2 (Erythrocyte protein 4.2;P4.2) ;
Alternative:
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Oligomer. Interacts with the cytoplasmic domain of SLC4A1/band 3 anion transport protein.
Function:
Probably plays an important role in the regulation of erythrocyte shape and mechanical properties.
Subcellular Location:
Cell membrane
Lipid-anchor
Cytoplasmic side
Cytoplasm
cytoskeleton
Cytoplasmic surface of erythrocyte membranes.
Protein Attributes:
50:
MGQALGIKSC | DFQAARNNEE | HHTKALSSRR | LFVRRGQPFT | IILYFRAPVR |
100:
AFLPALKKVA | LTAQTGEQPS | KINRTQATFP | ISSLGDRKWW | SAVVEERDAQ |
150:
SWTISVTTPA | DAVIGHYSLL | LQVSGRKQLL | LGQFTLLFNP | WNREDAVFLK |
200:
NEAQRMEYLL | NQNGLIYLGT | ADCIQAESWD | FGQFEGDVID | LSLRLLSKDK |
250:
QVEKWSQPVH | VARVLGALLH | FLKEQRVLPT | PQTQATQEGA | LLNKRRGSVP |
300:
ILRQWLTGRG | RPVYDGQAWV | LAAVACTVLR | CLGIPARVVT | TFASAQGTGG |
350:
RLLIDEYYNE | EGLQNGEGQR | GRIWIFQTST | ECWMTRPALP | QGYDGWQILH |
400:
PSAPNGGGVL | GSCDLVPVRA | VKEGTLGLTP | AVSDLFAAIN | ASCVVWKCCE |
450:
DGTLELTDSN | TKYVGNNIST | KGVGSDRCED | ITQNYKYPEG | SLQEKEVLER |
500:
VEKEKMEREK | DNGIRPPSLE | TASPLYLLLK | APSSLPLRGD | AQISVTLVNH |
550:
SEQEKAVQLA | IGVQAVHYNG | VLAAKLWRKK | LHLTLSANLE | KIITIGLFFS |
600:
NFERNPPENT | FLRLTAMATH | SESNLSCFAQ | EDIAICRPHL | AIKMPEKAEQ |
650:
YQPLTASVSL | QNSLDAPMED | CVISILGRGL | IHRERSYRFR | SVWPENTMCA |
691:
KFQFTPTHVG | LQRLTVEVDC | NMFQNLTNYK | SVTVVAPELS | A
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Human
Mouse
Bovine
ELISA Kit for Human Erythrocyte protein 4.2
ELISA Kit for Human Erythrocyte protein 4.2
ELISA Kit for Human Erythrocyte protein 4.2
CLIA Kit for Human Erythrocyte protein 4.2
CLIA Kit for Human Erythrocyte protein 4.2
CLIA Kit for Human Erythrocyte protein 4.2
Polyclonal Antibody for Human Erythrocyte protein 4.2
Polyclonal Antibody for Human Erythrocyte protein 4.2
Polyclonal Antibody for Human Erythrocyte protein 4.2
Monoclonal Antibody for Human Erythrocyte protein 4.2
Monoclonal Antibody for Human Erythrocyte protein 4.2
Monoclonal Antibody for Human Erythrocyte protein 4.2
Protein for Human Erythrocyte protein 4.2
Protein for Human Erythrocyte protein 4.2
Protein for Human Erythrocyte protein 4.2
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG)
tissue :
Reticulocyte .
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA];PARTIAL PROTEIN SEQUENCE (ISOFORM SHORT)
tissue :
Reticulocyte .
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT)
tissue :
Reticulocyte .
4.
"Analysis of the DNA sequence and duplication history of human chromosome 15."
Zody M.C.
,
Garber M.
,
Sharpe T.
,
Young S.K.
,
Rowen L.
,
O'Neill K.
,
Whittaker C.A.
,
Kamal M.
,
Chang J.L.
,
Cuomo C.A.
,
Dewar K.
,
FitzGerald M.G.
,
Kodira C.D.
,
Madan A.
,
Qin S.
,
Yang X.
,
Abbasi N.
,
Abouelleil A.
,
Arachchi H.M.
,
Baradarani L.
,
Birditt B.
,
Bloom S.
,
Bloom T.
,
Borowsky M.L.
,
Burke J.
,
Butler J.
,
Cook A.
,
DeArellano K.
,
DeCaprio D.
,
Dorris L. III
,
Dors M.
,
Eichler E.E.
,
Engels R.
,
Fahey J.
,
Fleetwood P.
,
Friedman C.
,
Gearin G.
,
Hall J.L.
,
Hensley G.
,
Johnson E.
,
Jones C.
,
Kamat A.
,
Kaur A.
,
Locke D.P.
,
Madan A.
,
Munson G.
,
Jaffe D.B.
,
Lui A.
,
Macdonald P.
,
Mauceli E.
,
Naylor J.W.
,
Nesbitt R.
,
Nicol R.
,
O'Leary S.B.
,
Ratcliffe A.
,
Rounsley S.
,
She X.
,
Sneddon K.M.B.
,
Stewart S.
,
Sougnez C.
,
Stone S.M.
,
Topham K.
,
Vincent D.
,
Wang S.
,
Zimmer A.R.
,
Birren B.W.
,
Hood L.
,
Lander E.S.
,
Nusbaum C.
more...
Nature440:671-675(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
5.
Mural R.J.
,
Istrail S.
,
Sutton G.G.
,
Florea L.
,
Halpern A.L.
,
Mobarry C.M.
,
Lippert R.
,
Walenz B.
,
Shatkay H.
,
Dew I.
,
Miller J.R.
,
Flanigan M.J.
,
Edwards N.J.
,
Bolanos R.
,
Fasulo D.
,
Halldorsson B.V.
,
Hannenhalli S.
,
Turner R.
,
Yooseph S.
,
Lu F.
,
Nusskern D.R.
,
Shue B.C.
,
Zheng X.H.
,
Zhong F.
,
Delcher A.L.
,
Huson D.H.
,
Kravitz S.A.
,
Mouchard L.
,
Reinert K.
,
Remington K.A.
,
Clark A.G.
,
Waterman M.S.
,
Eichler E.E.
,
Adams M.D.
,
Hunkapiller M.W.
,
Myers E.W.
,
Venter J.C.
more...
Submitted (2005-07) to the EMBL/GenBank/DDBJ databases
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
6.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS SHORT AND 3)
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : MYRISTOYLATION AT GLY-2
8.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : PHOSPHORYLATION AT SER-248
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT SPH5 THR-112
10.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT SPH5 THR-112
11.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT SPH5 GLN-280
12.
"Band 4.2 Shiga: 317 CGC-->TGC in compound heterozygotes with 142 GCT-->ACT results in band 4.2 deficiency and microspherocytosis."
Kanzaki A.
,
Yasunaga M.
,
Okamoto N.
,
Inoue T.
,
Yawata A.
,
Wada H.
,
Andoh A.
,
Hodohara K.
,
Fujiyama Y.
,
Bamba T.
,
Harano T.
,
Harano K.
,
Yawata Y.
Br. J. Haematol.91:333-340(1995)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS SPH5 THR-112 AND CYS-287
13.
"Band 4.2 Komatsu: 523 GAT-->TAT (175 Asp-->Tyr) in exon 4 of the band 4.2 gene associated with total deficiency of band 4.2, hemolytic anemia with ovalostomatocytosis and marked disruption of the cytoskeletal network."
Kanzaki A.
,
Yawata Y.
,
Yawata A.
,
Inoue T.
,
Okamoto N.
,
Wada H.
,
Harano T.
,
Harano K.
,
Wilmotte R.
,
Hayette S.
,
Nakamura Y.
,
Niki T.
,
Kawamura Y.
,
Nakamura S.
,
Matsuda T.
Int. J. Hematol.61:165-178(1995)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT SPH5 TYR-145
14.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT SPH5 THR-112